Armstrong DG, Orgill DP, Galiano RD, et al. - Addition of a unique resorbable glass microfiber matrix (Mirragen; Advanced Wound Matrix [BBGFM]; ETS Wound Care, Rolla, Missouri) to standard of care (SOC, collagen alginate dressing) in the treatment of diabetic foot ulcers (DFUs) led to a significant improvement in wound healing with no adverse events related to treatment when compared with treating with SOC alone.

• Seventy percent (14/20) of the BBGFM-treated DFUs healed compared with 25% (5/20) treated with SOC alone at 12 weeks.

• In the BBGFM group, mean percent area reduction (PAR) was 79% vs 37% in the SOC group at 12 weeks.

• The BBGFM vs SOC group showed mean change of 2.0 vs −0.6 in neuropathic score between baseline and up to 12 weeks of treatment where positive improvement in scores are better.

• On average, 6.0 BBGFM applications were required.